Bedridden with ME/CFS in their 20s, much better after iTMS and LDN
- Condition
- ME/CFS
- At worst
- Severe (mostly bedbound)
- Ill before improving or writing
- decades
- Last post
- Mar 2026
In their words
- Condition: ME/CFS
I have been a long-term ME/CFS sufferer for decades, but I got to a point many years ago where I could manage
In context ↗ - At worst: Severe
it certainly took its toll during my 20s, with many years bedridden
In context ↗ - Now: Much better
which did help reduce my symptoms, allowing me to return to work ... This trial resulted in considerable improvement in COVID symptoms as well
In context ↗ - Began after: COVID
between 2020 and 2022, I was infected 12 times with Covid-19
Read from 1 of their posts and comments; links to the one this page draws on
Summary
An Australian who had ME/CFS for decades, with years bedridden in their 20s, caught COVID-19 12 times between 2020 and 2022 and was diagnosed with long COVID in early 2022. Four rounds of iTMS over 18 months reduced symptoms and let them return to work. A low-dose naltrexone trial, in which they were confirmed not to have had placebo, brought considerable further improvement, and they now take prescribed LDN daily.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- 4 different Covid 'mRNA shots' · Not said
I had received 4 different Covid 'mRNA shots'
In context ↗ - iTMS · Helped
I received 4 rounds of iTMS (30 treatments each round, spread over 18 months), which did help reduce my symptoms, allowing me to return to work.
In context ↗ - Low Dose Naltrexone (LDN) · Helped a lot
This trial resulted in considerable improvement in COVID symptoms as well.
In context ↗
Approaches: Brain stimulation
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. 1 step says too little to place on the scale and is only in the table. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| decades ago | ME/CFS onset; many years bedridden in their 20sI have been a long-term ME/CFS sufferer for decades ... many years bedriddenIn context ↗ | Severe | |
| many years ago | reached a point where they could manageI got to a point many years ago where I could manageIn context ↗ | Mild | |
| 2020-2022 | 12 COVID-19 infections, then diagnosed with long COVID early 2022between 2020 and 2022, I was infected 12 times with Covid-19 ... Early in 2022, I was diagnosed with Long-COVIDIn context ↗ | Not stated | |
| after early 2022, over 18 months | symptoms reduced, returned to workI received 4 rounds of iTMS (30 treatments each round, spread over 18 months), which did help reduce my symptoms, allowing me to return to workIn context ↗ | Mild | rTMS (transcranial magnetic stimulation) |
| recently, as of March 2026 | considerable improvement on daily LDNThis trial resulted in considerable improvement in COVID symptoms as well. My specialist has now prescribed me with LDN, which I take daily.In context ↗ | Mild | Low-dose naltrexone |
Ask Miruvor AI
Similar stories
-
Largely bedridden with long COVID, now somewhat better on antivirals
She developed long COVID in 2022 after two COVID infections, and after a booster in November 2024 became largely bedridden and wheelchair-dependent; a mini stroke and a Sjögren's diagnosis followed. TMS, Plaquenil, peptides, nattokinase, antivirals and a…
-
Bedridden with ME/CFS; Xifaxan and FMT eased GI symptoms, mostly bedbound after LDN rise
Shore 57897 has had ME/CFS for over 20 years, at worst bedridden and getting up only to use the restroom. Xifaxan followed by FMT capsules greatly reduced their GI symptoms, and pacing helped. Low-dose naltrexone at 4.5 mg took the edge off, but a doctor's…
-
90% bedbound with ME/CFS, remission on LDN, then relapsed to mostly bedbound
Fjord 82756 dates their health decline to venlafaxine, which they came off more than ten years ago, and was 90% bedbound with ME/CFS by 2023, with chronic migraine and fibromyalgia too. After 18 months bedbound, they began low-dose naltrexone (4.5 mg) around…
-
Not enough detail to draw a path
Long COVID unable to work or drive, now much better with low-histamine diet and LDN
He developed long COVID after a COVID infection in about April 2024, becoming unable to work or drive. A low-histamine diet, famotidine, sleep supplements, TMS, low-dose naltrexone and peptides brought steady gains, and by June 2025 he rated himself 85–90%…